Press Releases BioNTech SE Börse Stuttgart

Equities

22UA

US09075V1026

Market Closed - Börse Stuttgart Other stock markets 02:01:02 2024-05-31 pm EDT			5-day change	1st Jan Change
92.5 ^EUR	+1.54%		+4.17%	+4.21%

May. 31	European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower	MT
May. 29	BioNTech, CEPI Expand Partnership for mRNA Vaccine Ecosystem in Africa	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)	10:00am	AQ
Patents, Policies And Privacy: The Highs And Lows Of Technology In IP	May. 31	AQ
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	May. 30	AQ
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 17 May 2024)	May. 30	PU
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 1 June 2022)	May. 30	PU
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 22 June 2021)	May. 30	PU
BioNTech : Publication of the resolutions and system for the remuneration of the members of the management Board (resolution of the AGM on 17 May 2024)	May. 30	PU
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem	May. 29	GL
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership	May. 26	PR
BioNTech : to Evaluate NanoTag’s Target Labeling System in Different Therapeutic Areas	May. 22	PU
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024	May. 21	GL
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024	May. 17	GL
BioNTech : Corporate Presentation	May. 13	PU
BioNTech : First Quarter 2024 Financial Report	May. 06	PU
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update	May. 06	GL
Moderna Litigation Against BioNTech And Pfizer Stayed Pending IPR	May. 06	AQ
GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech For Infringing MRNA Vaccine Patents	May. 03	AQ
BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Collaborations GmbH on the domination and profit and loss transfer agreement pursuant to Section 293a AktG	May. 02	PU
BioNTech : Report of the Management Board on Agenda Items 12 and 13 lit. c) and d)	May. 02	PU
BioNTech : Extracts from the minutes of the Annual General Meetings of 18 August 2017, 19 August 2019, 26 June 2020 and 22 June 2021 (2017/2019 share option program and 2021 share option program)	May. 02	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BIONTECH : A miss is a miss

March 21, 2024 at 09:27 am EDT